Linezolid for the treatment of infections a review of the clinical and cost-effectiveness

The purpose of this report is to examine the comparative clinical effectiveness of linezolid, vancomycin and daptomycin for Methicillin-resistant Staphylococcus aureus (MRSA) infections, the comparative clinical effectiveness of linezolid and daptomycin for the treatment of VRE infections, and the c...

Full description

Bibliographic Details
Main Authors: Kanga, Ismat, Poitras, Veronica (Author), Ford, Caitlyn (Author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa CADTH October 25, 2017, 2017
Edition:Version 1.0
Series:CADTH rapid response report: peer review with critical appraisal
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The purpose of this report is to examine the comparative clinical effectiveness of linezolid, vancomycin and daptomycin for Methicillin-resistant Staphylococcus aureus (MRSA) infections, the comparative clinical effectiveness of linezolid and daptomycin for the treatment of VRE infections, and the cost-effectiveness of linezolid and daptomycin for MRSA and vancomycin-resistant enterococci (VRE) infections. Additionally, the clinical effectiveness and cost-effectiveness of oral versus intravenous linezolid will be examined
Physical Description:1 PDF file (60 pages) illustration